文献速递类风湿关节炎其他结缔组织病

类风湿关节炎相关间质性肺病临床与遗传风险评分的开发及内部验证

Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

在大型多中心前瞻性类风湿关节炎(RA)队列中,基于12个特发性肺纤维化相关单核苷酸多态性构建遗传风险评分并与临床危险因素联合建模,联合模型区分间质性肺病(ILD)的能力优于单纯临床模型(AUC 0.675 vs 0.635,P < 0.001),可使20%队列因综合风险评分低于高敏感度切点而免于低产出检查。

要点

  • 在2386例RA患者中,9.4%患有ILD,联合遗传与临床因素的模型区分ILD优于单纯临床模型(AUC 0.675 vs 0.635,P < 0.001)。
  • 收缩校正后联合模型与单纯临床模型的AUC分别为0.667(95% CI 0.628, 0.712)和0.623(95% CI 0.584, 0.651)。
  • 20%的队列综合风险评分低于敏感度>90%的切点,可排除于低产出检查之外。

核心结论

  • 在大型多中心RA队列中,临床与遗传风险模型区分ILD优于单纯临床模型,可将20%队列排除于低产出检查之外。
  • 作者认为遗传风险评分在RA-ILD中具有潜在应用价值,并支持进一步研究个体化风险分层与筛查。

研究设计与样本

  • 研究为在大型多中心前瞻性RA队列(退伍军人事务部RA登记处)中开发并内部验证ILD风险模型。
  • 对12个与特发性肺纤维化相关的单核苷酸多态性进行基因分型,ILD经系统病历回顾验证。
  • 采用后向选择法,按与ILD的效应量对次要等位基因加权计算遗传风险评分,并与临床危险因素一起纳入逻辑回归模型。
  • 内部验证采用自举法,模型性能以受试者工作特征曲线下面积(AUC)评估。

主要发现

  • 2386例参与者中89%为男性,平均年龄69.5岁,9.4%患有ILD。
  • 后向选择后,5个单核苷酸多态性纳入遗传风险评分。
  • 遗传风险评分联合临床因素区分ILD优于单纯临床因素(AUC 0.675 vs 0.635,P < 0.001)。
  • 收缩校正后联合模型与单纯临床模型的性能分别为0.667(95% CI 0.628, 0.712)和0.623(95% CI 0.584, 0.651)。
  • 20%的队列综合风险评分低于敏感度>90%的切点。

关键数值与推荐

  • 联合模型区分ILD的AUC为0.675,单纯临床模型为0.635(P < 0.001)。
  • 收缩校正后联合模型AUC为0.667(95% CI 0.628, 0.712),单纯临床模型为0.623(95% CI 0.584, 0.651)。
  • 20%的队列综合风险评分低于敏感度>90%的切点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Although clinical and genetic risk factors have been identified for rheumatoid arthritis-associated interstitial lung disease (RA-ILD), there are no current tools allowing for risk stratification. We sought to develop and validate an ILD risk model in a large, multicentre, prospective RA cohort. METHODS: Participants in the Veterans Affairs RA (VARA) registry were genotyped for 12 single nucleotide polymorphisms (SNPs) associated with idiopathic pulmonary fibrosis. ILD was validated through systematic record review. A genetic risk score (GRS) was computed from minor alleles weighted by effect size with ILD, using backward selection. The GRS was combined with clinical risk factors within a logistic regression model. Internal validation was completed using bootstrapping, and model performance was assessed by the area under the receiver operating curve (AUC). RESULTS: Of 2386 participants (89% male, mean age 69.5 years), 9.4% had ILD. Following backward selection, five SNPs contributed to the GRS. The GRS and clinical factors outperformed clinical factors alone in discriminating ILD (AUC 0.675 vs 0.635, P < 0.001). The shrinkage-corrected performance for combined and clinical-only models was 0.667 (95% CI 0.628, 0.712) and 0.623 (95% CI 0.584, 0.651), respectively. Twenty percent of the cohort had a combined risk score below a cut-point with >90% sensitivity. CONCLUSION: A clinical and genetic risk model discriminated ILD in a large, multicentre RA cohort better than a clinical-only model, excluding 20% of the cohort from low-yield testing. These results demonstrate the potential utility of a GRS in RA-ILD and support further investigation into individualized risk stratification and screening.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Wheeler AM, Baker JF, Riley T, et al. Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease. Rheumatology (Oxford). 2025. PMID: 38243706. doi:10.1093/rheumatology/keae001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。